Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2208 to 2257 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
clathrin coat assembly protein ap50 (clathrin coat associated protein ap50) (plasma membrane adaptor ap-2 50 kda protein) (ha2 50 kda subunit) (clathrin assembly protein complex 2 medium chain) (ap-2 mu 2 chain). [source:swissprot;acc:p20172]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
199.129\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
200.413\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00645\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-binding cassette, sub-family c, member 10; multidrug resistance-associated protein 7. [source:refseq;acc:nm\_033450]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal alpha-mannosidase precursor (ec 3.2.1.24) (mannosidase, alpha b) (lysosomal acid alpha-mannosidase) (laman) (mannosidase alpha class 2b member 1). [source:swissprot;acc:o00754]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna polymerase i transcription factor rrn3. [source:refseq;acc:nm\_018427]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s16, mitochondrial precursor (mrp-s16) (cgi- 132). [source:swissprot;acc:q9y3d3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00643\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dimeric dihydrodiol dehydrogenase; 3-deoxyglucosone reductase. [source:refseq;acc:nm\_014475]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.127\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.475\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00642\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, adipocyte (afabp) (adipocyte lipid-binding protein) (albp) (a-fabp). [source:swissprot;acc:p15090]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
221.509\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.108\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00637\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, epidermal (e-fabp) (psoriasis-associated fatty acid-binding protein homolog) (pa-fabp). [source:swissprot;acc:q01469]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, brain (b-fabp) (brain lipid-binding protein) (blbp) (mammary derived growth inhibitor related). [source:swissprot;acc:o15540]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein 4. [source:swissprot;acc:p57081]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myelin p2 protein. [source:swissprot;acc:p02689]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kelch-like protein 8. [source:swissprot;acc:q9p2g9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylethanolamine n-methyltransferase (ec 2.1.1.28) (pnmtase) (noradrenaline n-methyltransferase). [source:swissprot;acc:p11086]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene 15, 15'-dioxygenase; beta-carotene 15,15'-monooxygenase. [source:refseq;acc:nm\_017429]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid-binding protein, heart (h-fabp) (muscle fatty acid-binding protein) (m-fabp) (mammary-derived growth inhibitor) (mdgi). [source:swissprot;acc:p05413]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinal pigment epithelium-specific protein 65kda; retinal pigment epithelium-specific protein (65kd); retinitis pigmentosa 20 (autosomal recessive). [source:refseq;acc:nm\_000329]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
indolethylamine n-methyltransferase (ec 2.1.1.49) (aromatic alkylamine n-methyltransferase) (indolamine n-methyltransferase) (arylamine n- methyltransferase) (amine n-methyltransferase). [source:swissprot;acc:o95050]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cofilin, non-muscle isoform (18 kda phosphoprotein) (p18). [source:swissprot;acc:p23528]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.955\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.336\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00634\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2227\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cofilin, muscle isoform (cofilin 2). [source:swissprot;acc:q9y281]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2228\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadph:adrenodoxin oxidoreductase, mitochondrial precursor (ec 1.18.1.2) (adrenodoxin reductase) (ar) (ferredoxin-nadp(+) reductase). [source:swissprot;acc:p22570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.153\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
destrin (actin-depolymerizing factor) (adf). [source:swissprot;acc:p18282]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.955\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.336\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin fusion degradation protein 1 homolog (ub fusion protein 1). [source:swissprot;acc:q92890]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2231\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hrd1 protein isoform a; synoviolin1. [source:refseq;acc:nm\_032431]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.842\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.246\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00633\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2232\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
43 kda receptor-associated protein of the synapse (rapsyn) (acetylcholine receptor-associated 43 kda protein) (43 kda postsynaptic protein). [source:swissprot;acc:q13702]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.547\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00632\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tripartite motif protein 3 (ring finger protein 22) (brain-expressed ring finger protein). [source:swissprot;acc:o75382]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.414\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.691\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00631\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seven in absentia homolog 1. [source:refseq;acc:nm\_003031]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.608\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.005\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00625\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2235\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginyl-trna synthetase-like; arginine-trna ligase. [source:refseq;acc:nm\_020320]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
200.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
199.711\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0062\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein regulator of cytokinesis 1; protein regulating cytokinesis 1. [source:refseq;acc:nm\_003981]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.959\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.337\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00618\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2237\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bromodomain-containing protein 3 (ring3-like protein). [source:swissprot;acc:q15059]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.965\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.343\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2238\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bromodomain-containing protein 4 (hunk1 protein). [source:swissprot;acc:o60885]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.959\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.337\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2239\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific bromodomain protein. [source:refseq;acc:nm\_001726]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.958\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.336\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nag14 protein. [source:refseq;acc:nm\_022143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.959\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.337\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2241\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bromodomain-containing protein 2 (ring3 protein) (o27.1.1). [source:swissprot;acc:p25440]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
222.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.338\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2242\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2b (transmembrane protein bri) [contains: abri/adan amyloid peptide]. [source:swissprot;acc:q9y287]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
209.197\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
207.915\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00617\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2243\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2c (transmembrane protein bri3) (npd018). [source:swissprot;acc:q9nqx7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
integral membrane protein 2a (e25 protein). [source:swissprot;acc:o43736]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fibulin-2 precursor. [source:swissprot;acc:p98095]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.618\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
190.448\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00614\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l18. [source:refseq;acc:nm\_014161]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.943\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sipl protein. [source:refseq;acc:nm\_018269]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2248\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif3c. [source:swissprot;acc:o14782]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.045\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.377\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00608\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate carboxylase, mitochondrial precursor (ec 6.4.1.1) (pyruvic carboxylase) (pcb). [source:swissprot;acc:p11498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
181.091\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
179.999\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00607\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
likely ortholog of mouse variant polyadenylation protein cstf-64. [source:refseq;acc:nm\_015235]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
164.064\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
165.058\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00606\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
e-1 enzyme. [source:refseq;acc:nm\_021204]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
208.315\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.061\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta-aminolevulinic acid dehydratase (ec 4.2.1.24) (porphobilinogen synthase) (aladh). [source:swissprot;acc:p13716]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.498\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif3b (microtubule plus end-directed kinesin motor 3b) (hh0048). [source:swissprot;acc:o15066]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.047\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.371\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00604\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 3 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 3). [source:swissprot;acc:p47986]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
193.065\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
194.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00598\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-fetoprotein enhancer binding protein (at motif-binding factor) (at-binding transcription factor 1). [source:swissprot;acc:q15911]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.366\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00595\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
seven in absentia homolog 2. [source:refseq;acc:nm\_005067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
223.546\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
224.869\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00592\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nicotinate-nucleotide pyrophosphorylase [carboxylating] (ec 2.4.2.19) (quinolinate phosphoribosyltransferase [decarboxylating]) (qaprtase) (qprtase). [source:swissprot;acc:q15274]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.563\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.315\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00591\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/